@yaireinhorn 1 year ago
2/In @doudna_lab’s vision - the future of #CRISPR #GeneEditing will intersect with other #technologies such as #MachineLearning, cell #Imaging & #Sequencing while #FDA approval for the first $CRSP CRISPR-based medicine will help advance others to later stages of #clinicaltrials. https://t.co/lRcaNmatQv
@bgr.com 1 year ago
Scientists tricked mosquitoes into delivering vaccines to humans
@techcrunch.com 2 years ago
How Colossal sold investors on a quest to resurrect a woolly mammoth
@techcrunch.com 4 years ago
DNA Script picks up $38.5 million to make DNA production faster and simpler
@xconomy.com 4 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com 5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com 5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com 5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@techcrunch.com 7 years ago
Innovation in genomics and the future of medtech